Feature | December 24, 2013

World’s First Mevion S250 Proton Therapy Treatment Delivered at Barnes-Jewish Hospital

proton therapy radiation therapy mevion s250
December 24, 2013 — A patient with a rare type of cancer (chondrosarcoma) at the base of the skull has become the first person in the world to receive proton therapy using the Mevion S250 proton therapy system from Mevion Medical Systems Inc. of Littleton, Mass. Radiation oncologists at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis delivered the treatment. The S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital is home to the Mevion S250, a proton therapy device designed to deliver the same precise, non-invasive treatments delivered by conventional proton systems but with a reduced physical footprint, streamlined clinical workflow and lower implementation and operational costs.
 
“We are extremely pleased and proud to open the Kling Proton Therapy Center for the St. Louis community and beyond,” said Rich Liekweg, president, Barnes-Jewish Hospital. The closest proton therapy center is over 230 miles away from St. Louis. “The ability to add proton therapy to our world-class cancer care program in a significantly smaller and more economical package is imperative in today’s challenging health care environment. Barnes-Jewish Hospital is the first in the world to operate a single-room proton therapy system and the addition of this advanced technology continues our tradition of providing the best care for our patients.”
 
Proton therapy delivers highly precise doses of radiation while limiting unnecessary radiation to healthy tissue, potentially decreasing radiation side effects and improving patient outcomes. Mevion’s ability to provide proton therapy in a compact form provides patients and clinicians access to proton therapy without the high entry and maintenance costs plaguing conventional proton systems. 
 
“The ability to treat with this advanced technology is no longer encumbered by astronomical costs, prohibitive space requirements and technologically cumbersome systems that to date have defined this treatment modality,” said Joseph Jachinowski, CEO, Mevion Medical Systems. “The Mevion S250 proves that all the benefits and more of these legacy proton therapy systems can be delivered in a fiscally responsible manner.”
 
The pioneering proton team at the Kling Proton Therapy Center has been working for the past several months running the Mevion S250 through independent clinical quality assurance tests to ensure that system specifications, safety and reliability requirements are met. 
 
“The advanced clinical workflow provided by the Mevion S250 and its full integration within the clinic has made it simple and straightforward to train the radiation therapy staff and prepare their clinic for day-to-day treatments,” said Stanley Rosenthal, Ph.D.,vice president, clinical systems and education, Mevion. “The initial training experience of the therapists demonstrates that the Mevion S250 workflow and delivery times are comparable to today’s image-guided radiation therapy techniques.”
 
Four additional Mevion S250 proton therapy systems are under installation at Robert Wood Johnson University Hospital, New Brunswick, N.J.; the Stephenson Cancer Center, Oklahoma University, Oklahoma City; First Coast Oncology, Jacksonville, Fla.; and the Proton Therapy Center, Orlando Health, Orlando, Fla. In addition, the Seidman Cancer Center at University Hospitals, Cleveland, broke ground on its Mevion S250 center in September and has taken delivery of the first system module.
 
For more information: www.mevion.com

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init